Tim R. Eijgenraam

523 total citations
13 papers, 277 citations indexed

About

Tim R. Eijgenraam is a scholar working on Cardiology and Cardiovascular Medicine, Oncology and Molecular Biology. According to data from OpenAlex, Tim R. Eijgenraam has authored 13 papers receiving a total of 277 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Cardiology and Cardiovascular Medicine, 4 papers in Oncology and 3 papers in Molecular Biology. Recurrent topics in Tim R. Eijgenraam's work include Cardiomyopathy and Myosin Studies (7 papers), Cardiovascular Effects of Exercise (3 papers) and Viral Infections and Immunology Research (2 papers). Tim R. Eijgenraam is often cited by papers focused on Cardiomyopathy and Myosin Studies (7 papers), Cardiovascular Effects of Exercise (3 papers) and Viral Infections and Immunology Research (2 papers). Tim R. Eijgenraam collaborates with scholars based in Netherlands, United States and Sweden. Tim R. Eijgenraam's co-authors include Rudolf A. de Boer, Herman H.W. Silljé, Jolanda van der Velden, Elisabeth M. Schouten, Peter van der Meer, Quint A. J. Hagdorn, Rolf M.F. Berger, Diederik E. van der Feen, Guido P. L. Bossers and Cornelis J. Boogerd and has published in prestigious journals such as Circulation Research, Scientific Reports and International Journal of Molecular Sciences.

In The Last Decade

Tim R. Eijgenraam

12 papers receiving 277 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Tim R. Eijgenraam Netherlands	9	164	98	41	27	26	13	277
Shiow J. Lin United States	6	102 0.6×	98 1.0×	45 1.1×	16 0.6×	16 0.6×	9	297
Elise L. Kessler Netherlands	10	193 1.2×	106 1.1×	17 0.4×	22 0.8×	18 0.7×	19	325
Akhil Pampana United States	6	70 0.4×	62 0.6×	28 0.7×	16 0.6×	21 0.8×	19	205
Coenraad Withaar Netherlands	7	235 1.4×	100 1.0×	56 1.4×	23 0.9×	21 0.8×	7	384
Pedro A. Sousa Portugal	9	199 1.2×	71 0.7×	35 0.9×	33 1.2×	16 0.6×	51	326
Shirin Zarafshar United States	6	143 0.9×	104 1.1×	31 0.8×	24 0.9×	6 0.2×	9	294
Shalaimaiti Shali China	7	89 0.5×	194 2.0×	25 0.6×	19 0.7×	9 0.3×	14	309
Datun Qi China	10	147 0.9×	94 1.0×	16 0.4×	31 1.1×	10 0.4×	34	277
Eva Cecilie Knudsen Norway	9	101 0.6×	76 0.8×	15 0.4×	34 1.3×	18 0.7×	13	237
Guido Carlomagno Italy	8	120 0.7×	57 0.6×	31 0.8×	35 1.3×	25 1.0×	21	223

Countries citing papers authored by Tim R. Eijgenraam

Since Specialization

Citations

This map shows the geographic impact of Tim R. Eijgenraam's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Tim R. Eijgenraam with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Tim R. Eijgenraam more than expected).

Fields of papers citing papers by Tim R. Eijgenraam

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Tim R. Eijgenraam. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Tim R. Eijgenraam. The network helps show where Tim R. Eijgenraam may publish in the future.

Co-authorship network of co-authors of Tim R. Eijgenraam

This figure shows the co-authorship network connecting the top 25 collaborators of Tim R. Eijgenraam. A scholar is included among the top collaborators of Tim R. Eijgenraam based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Tim R. Eijgenraam. Tim R. Eijgenraam is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

13 of 13 papers shown

Eijgenraam, Tim R., Niels Kloosterhuis, Rick Havinga, et al.. (2025). The impact of a humanized bile acid composition on atherosclerosis development in hypercholesterolaemic Cyp2c70 knockout mice. Scientific Reports. 15(1). 2100–2100. 2 indexed citations

Sun, Liu, Tim R. Eijgenraam, David Janzén, et al.. (2025). In PLN-R14del mice, SR structure restoration, rather than calcium cycling, is the dominant effector of PLN-ASO treatment. Cardiovascular Research. 121(13). 2042–2054.

Vries, H. de, Tim R. Eijgenraam, Vincent W. Bloks, et al.. (2024). Elevated plasma bile acids coincide with cardiac stress and inflammation in young Cyp2c70−/− mice. Pediatric Research. 97(6). 2145–2152. 2 indexed citations

Suthahar, Navin, Kan Wang, Stephan J. L. Bakker, et al.. (2023). Associations of relative fat mass, a new index of adiposity, with type-2 diabetes in the general population. European Journal of Internal Medicine. 109. 73–78. 40 indexed citations

Eijgenraam, Tim R., Elisabeth M. Schouten, Diederik W.D. Kuster, et al.. (2023). DWORF Extends Life Span in a PLN-R14del Cardiomyopathy Mouse Model by Reducing Abnormal Sarcoplasmic Reticulum Clusters. Circulation Research. 133(12). 1006–1021. 18 indexed citations

Eijgenraam, Tim R., Remco de Brouwer, Elisabeth M. Schouten, et al.. (2022). Antisense Therapy Attenuates Phospholamban p.(Arg14del) Cardiomyopathy in Mice and Reverses Protein Aggregation. International Journal of Molecular Sciences. 23(5). 2427–2427. 16 indexed citations

Aboumsallem, Joseph Pierre, Sanne de Wit, George Markousis‐Mavrogenis, et al.. (2022). Multi-omics analyses identify molecular signatures with prognostic values in different heart failure aetiologies. Journal of Molecular and Cellular Cardiology. 175. 13–28. 14 indexed citations

Eijgenraam, Tim R., Cornelis J. Boogerd, Martin M. Dokter, et al.. (2021). Protein Aggregation Is an Early Manifestation of Phospholamban p.(Arg14del)–Related Cardiomyopathy: Development of PLN-R14del–Related Cardiomyopathy. Circulation Heart Failure. 14(11). e008532–e008532. 24 indexed citations

Boer, Rudolf A. de, Louise L.A.M. Nijenkamp, Herman H.W. Silljé, et al.. (2020). Strength of patient cohorts and biobanks for cardiomyopathy research. Netherlands Heart Journal. 28(S1). 50–56. 1 indexed citations

10.

Eijgenraam, Tim R., Bastiaan J. Boukens, Cornelis J. Boogerd, et al.. (2020). The phospholamban p.(Arg14del) pathogenic variant leads to cardiomyopathy with heart failure and is unresponsive to standard heart failure therapy. Scientific Reports. 10(1). 9819–9819. 42 indexed citations

11.

Eijgenraam, Tim R., Herman H.W. Silljé, & Rudolf A. de Boer. (2019). Current understanding of fibrosis in genetic cardiomyopathies. Trends in Cardiovascular Medicine. 30(6). 353–361. 57 indexed citations

12.

Faiz, Alen, Katrina Steiling, Mirjam P. Roffel, et al.. (2019). Effect of long-term corticosteroid treatment on microRNA and gene-expression profiles in COPD. European Respiratory Journal. 53(4). 1801202–1801202. 25 indexed citations

13.

Hagdorn, Quint A. J., Guido P. L. Bossers, Arnold Piek, et al.. (2019). A novel method optimizing the normalization of cardiac parameters in small animal models: the importance of dimensional indexing. American Journal of Physiology-Heart and Circulatory Physiology. 316(6). H1552–H1557. 36 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact